Access to anti-retroviral drugs, male in Jamaica

Jamaica: Access to anti-retroviral drugs, male was 47.0% in 2024. ◆ Volatile

Latest (2024)
47.0%
Change on year
up 2.2%
World rank
122nd
of 141 countries
All-time high
47.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Jamaica, 2000–2024

010203040502000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 4 %2006: 5 %2007: 8 %2008: 10 %2009: 15 %2010: 18 %2011: 20 %2012: 24 %2013: 24 %2014: 27 %2015: 30 %2016: 33 %2017: 35 %2018: 38 %2019: 42 %2020: 39 %2021: 42 %2022: 45 %2023: 46 %2024: 47 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Jamaica is 47.0%, measured in 2024. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 2.2% on the previous year and up 74.1% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Jamaica peaked at 47.0% in 2024 and was at its lowest, 0.0%, in 2000.

Jamaica ranks 122nd of 141 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Jamaica, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Jamaica, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 4.0%
2006 5.0% +25.0%
2007 8.0% +60.0%
2008 10.0% +25.0%
2009 15.0% +50.0%
2010 18.0% +20.0%
2011 20.0% +11.1%
2012 24.0% +20.0%
2013 24.0% +0.0%
2014 27.0% +12.5%
2015 30.0% +11.1%
2016 33.0% +10.0%
2017 35.0% +6.1%
2018 38.0% +8.6%
2019 42.0% +10.5%
2020 39.0% -7.1%
2021 42.0% +7.7%
2022 45.0% +7.1%
2023 46.0% +2.2%
2024 47.0% +2.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 4.2% 0.0% 15.0% 10
2010s 29.1% 18.0% 42.0% 10
2020s 43.8% 39.0% 47.0% 5

Countries ranked near Jamaica

  1. 119 Libya 49.0% compare
  2. 120 Belize 48.0% compare
  3. 120 Kyrgyzstan 48.0% compare
  4. 122 Republic of Moldova 47.0% compare
  5. 122 Qatar 47.0% compare
  6. 125 Bangladesh 45.0% compare

See the full ranking of 160 places →

More gender data for Jamaica

All data for Jamaica →

Frequently asked questions

What is access to anti-retroviral drugs, male in Jamaica?
Access to anti-retroviral drugs, male in Jamaica was 47.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Jamaica?
The highest recorded value was 47.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Jamaica?
The lowest recorded value was 0.0% in 2000.
How does Jamaica rank for access to anti-retroviral drugs, male?
Jamaica ranks 122nd out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Jamaica?
Over the last ten years it is up 74.1%. The long-run trend across the full record is volatile.
Where does this Jamaica data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Jamaica. Statizoid, drawing on UNAIDS estimates. Retrieved 12 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/jamaica/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/jamaica/">Access to anti-retroviral drugs, male in Jamaica</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.